News

Royalty

Eton Pharmaceuticals — Small Cap Orphan Drug + Royalty Hybrid With Multiple FDA Arrows

Edward Kim | Equities.com |

Eton now has six FDA-approved commercial products in launch phase with four additional submissions that have been made to the FDA.


Sponsored Financial Content

Market Movers